Your browser doesn't support javascript.
loading
ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome.
Martin-Loeches, Ignacio; Motos, Anna; Menéndez, Rosario; Gabarrús, Albert; González, Jessica; Fernández-Barat, Laia; Ceccato, Adrián; Pérez-Arnal, Raquel; García-Gasulla, Dario; Ferrer, Ricard; Riera, Jordi; Lorente, José Ángel; Peñuelas, Óscar; Bermejo-Martin, Jesús F; de Gonzalo-Calvo, David; Rodríguez, Alejandro; Barbé, Ferran; Aguilera, Luciano; Amaya-Villar, Rosario; Barberà, Carme; Barberán, José; Blandino Ortiz, Aaron; Bustamante-Munguira, Elena; Caballero, Jesús; Carbajales, Cristina; Carbonell, Nieves; Catalán-González, Mercedes; Galbán, Cristóbal; Gumucio-Sanguino, Víctor D; de la Torre, Maria Del Carmen; Díaz, Emili; Gallego, Elena; García Garmendia, José Luis; Garnacho-Montero, José; Gómez, José M; Jorge García, Ruth Noemí; Loza-Vázquez, Ana; Marín-Corral, Judith; Martínez de la Gándara, Amalia; Martínez Varela, Ignacio; Lopez Messa, Juan; Albaiceta, Guillermo M; Novo, Mariana Andrea; Peñasco, Yhivian; Ricart, Pilar; Urrelo-Cerrón, Luis; Sánchez-Miralles, Angel; Sancho Chinesta, Susana; Socias, Lorenzo; Solé-Violan, Jordi.
Afiliação
  • Martin-Loeches I; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Motos A; Pulmonary Department, Hospital Clinic, Universitat de Barcelona, IDIBAPS, 08036 Barcelona, Spain.
  • Menéndez R; Department of Intensive Care Medicine, St. James's Hospital, Multidisciplinary Intensive Care Research Organization (MICRO), James's Street, D08 NHY1 Dublin, Ireland.
  • Gabarrús A; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • González J; Department of Intensive Care Medicine, St. James's Hospital, Multidisciplinary Intensive Care Research Organization (MICRO), James's Street, D08 NHY1 Dublin, Ireland.
  • Fernández-Barat L; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Ceccato A; Pulmonary Department, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
  • Pérez-Arnal R; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • García-Gasulla D; Pulmonary Department, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
  • Ferrer R; Translational Research in Respiratory Medicine Group (TRRM), Lleida Biomedical Research Institute (IRBLleida), 25198 Lleida, Spain.
  • Riera J; Pulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, 25198 Lleida, Spain.
  • Lorente JÁ; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Peñuelas Ó; Department of Intensive Care Medicine, St. James's Hospital, Multidisciplinary Intensive Care Research Organization (MICRO), James's Street, D08 NHY1 Dublin, Ireland.
  • Bermejo-Martin JF; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • de Gonzalo-Calvo D; Department of Intensive Care Medicine, St. James's Hospital, Multidisciplinary Intensive Care Research Organization (MICRO), James's Street, D08 NHY1 Dublin, Ireland.
  • Rodríguez A; Barcelona Supercomputing Centre (BSC), 08034 Barcelona, Spain.
  • Barbé F; Barcelona Supercomputing Centre (BSC), 08034 Barcelona, Spain.
  • Aguilera L; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Amaya-Villar R; Intensive Care Department, Vall d'Hebron Hospital Universitari, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
  • Barberà C; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Barberán J; Intensive Care Department, Vall d'Hebron Hospital Universitari, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
  • Blandino Ortiz A; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Bustamante-Munguira E; Hospital Universitario de Getafe, 28905 Madrid, Spain.
  • Caballero J; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Carbajales C; Hospital Universitario de Getafe, 28905 Madrid, Spain.
  • Carbonell N; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Catalán-González M; Hospital Universitario Río Hortega de Valladolid, 47012 Valladolid, Spain.
  • Galbán C; Instituto de Investigación Biomédica de Salamanca (IBSAL), Gerencia Regional de Salud de Castilla y León, 47007 Valladolid, Spain.
  • Gumucio-Sanguino VD; Translational Research in Respiratory Medicine Group (TRRM), Lleida Biomedical Research Institute (IRBLleida), 25198 Lleida, Spain.
  • de la Torre MDC; Pulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, 25198 Lleida, Spain.
  • Díaz E; Critical Care Department, Hospital Joan XXIII, 43005 Tarragona, Spain.
  • Gallego E; Translational Research in Respiratory Medicine Group (TRRM), Lleida Biomedical Research Institute (IRBLleida), 25198 Lleida, Spain.
  • García Garmendia JL; Pulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, 25198 Lleida, Spain.
  • Garnacho-Montero J; Anestesia, Reanimación y Terapia del Dolor, Hospital Universitario de Basurto, 48013 Bilbao, Spain.
  • Gómez JM; Intensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, 41013 Sevilla, Spain.
  • Jorge García RN; Hospital Santa Maria, IRBLleida, 25198 Lleida, Spain.
  • Loza-Vázquez A; Critical Care Department, Hospital Universitario HM Montepríncipe, Universidad San Pablo-CEU, 28660 Madrid, Spain.
  • Marín-Corral J; Servicio de Medicina Intensiva, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Martínez de la Gándara A; Department of Intensive Care Medicine, Hospital Clínico Universitario Valladolid, 47003 Valladolid, Spain.
  • Martínez Varela I; Critical Care Department, Hospital Universitari Arnau de Vilanova, IRBLleida, 25198 Lleida, Spain.
  • Lopez Messa J; Hospital Álvaro Cunqueiro, 36213 Vigo, Spain.
  • Albaiceta GM; Intensive Care Unit, Hospital Clínico y Universitario de Valencia, 46010 Valencia, Spain.
  • Novo MA; Department of Intensive Care Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Peñasco Y; Department of Medicine, CHUS, Complejo Hospitalario Universitario de Santiago, 15076 Santiago de Compostela, Spain.
  • Ricart P; Department of Intensive Care, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Urrelo-Cerrón L; Hospital de Mataró de Barcelona, 08301 Mataró, Spain.
  • Sánchez-Miralles A; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Critical Care Department, Corpo-Ració Sanitària Parc Taulí, Sabadell, 08208 Barcelona, Spain.
  • Sancho Chinesta S; Unidad de Cuidados Intensivos, Hospital San Pedro de Alcántara, 10003 Cáceres, Spain.
  • Socias L; Intensive Care Unit, Hospital San Juan de Dios del Aljarafe, 41930 Sevilla, Spain.
  • Solé-Violan J; Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
J Clin Med ; 11(1)2021 12 31.
Article em En | MEDLINE | ID: mdl-35011967
BACKGROUND: Some patients previously presenting with COVID-19 have been reported to develop persistent COVID-19 symptoms. While this information has been adequately recognised and extensively published with respect to non-critically ill patients, less is known about the incidence and factors associated with the characteristics of persistent COVID-19. On the other hand, these patients very often have intensive care unit-acquired pneumonia (ICUAP). A second infectious hit after COVID increases the length of ICU stay and mechanical ventilation and could have an influence on poor health post-COVID 19 syndrome in ICU-discharged patients. METHODS: This prospective, multicentre, and observational study was carrid out across 40 selected ICUs in Spain. Consecutive patients with COVID-19 requiring ICU admission were recruited and evaluated three months after hospital discharge. RESULTS: A total of 1255 ICU patients were scheduled to be followed up at 3 months; however, the final cohort comprised 991 (78.9%) patients. A total of 315 patients developed ICUAP (97% of them had ventilated ICUAP). Patients requiring invasive mechanical ventilation had more persistent post-COVID-19 symptoms than those who did not require mechanical ventilation. Female sex, duration of ICU stay, development of ICUAP, and ARDS were independent factors for persistent poor health post-COVID-19. CONCLUSIONS: Persistent post-COVID-19 symptoms occurred in more than two-thirds of patients. Female sex, duration of ICU stay, development of ICUAP, and ARDS all comprised independent factors for persistent poor health post-COVID-19. Prevention of ICUAP could have beneficial effects in poor health post-COVID-19.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article